Download PDF
Semin Speech Lang 2004; 25(3): 207-213
DOI: 10.1055/s-2004-833668
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Emerging Issues and Trends in Attention Deficit Hyperactivity Disorder: An Update for the Speech-Language Pathologist

Jack S. Damico1 , John A. Tetnowski1 , Sandra K. Nettleton2
  • 1Department of Communicative Disorders, The University of Louisiana at Lafayette, Lafayette, Louisiana
  • 2Albuquerque Public Schools, Albuquerque, New Mexico
Further Information

Publication History

Publication Date:
10 September 2004 (online)

    Permissions and Reprints

There are many trends in the diagnosis and treatment of attention deficit hyperactivity disorder (ADHD) that have emerged over the past several years. The first of these emerging trends is the growing prevalence of ADHD diagnoses across age groups and cultures. Although the causes of this growing prevalence are unclear, several suggestions, including a broader definition of ADHD, are discussed as potential contributions. A second emerging issue is related to the underlying theory of ADHD. Barkley's biopsychosocial model of ADHD is briefly discussed as a prototype model to help in the understanding of ADHD. Finally, the growing trend in pharmacological treatment of ADHD is discussed. Stimulant medications, as well as a recent nonstimulant medication are discussed and compared with nonpharmacological alternatives.

KEYWORDS

ADHD - trends - medication - theory

REFERENCES

  • 1 Augustine L, Damico J S. Attention deficit hyperactivity disorder: the scope of the problem.  Semin Speech Lang. 1995;  16 243-258
    PubMedGoogle Scholar
  • 2 Volkmar F R. Changing perspectives on ADHD.  Am J Psychiatry. 2003;  160 1025-1027
    CrossrefPubMedGoogle Scholar
  • 3 Lord J, Paisley S. The Clinical Effectiveness and Cost Effectiveness of Methylphenidate for Hyperactivity in Childhood, Version 2. London; National Institute for Clinical Excellence 2000
    Google Scholar
  • 4 Scahill L, Schwab-Stone M. Epidemiology of ADHD in school-age children.  Child Adolesc Psychiatr Clin N Am. 2000;  9 541-555
    PubMedGoogle Scholar
  • 5 Clegg J, Hartshorne M. Speech and language therapy in hyperactivity: a United Kingdom perspective in complex cases.  Semin Speech Lang. 2004;  25 263-270
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Swanson J M, Sergeant J A, Taylor E et al.. Attention-deficit hyperactivity disorder and hyperkinetic disorder.  Lancet. 1998;  351 429-433
    CrossrefPubMedGoogle Scholar
  • 7 Taylor E, Sergeant J, Doepfner M et al.. Clinical guidelines for hyperkinetic disorder.  Eur Child Adolesc Psychiatry. 1998;  7 184-200
    CrossrefPubMedGoogle Scholar
  • 8 Jouglin C, Zwi M. FOCUS on the Use of Stimulants in Children With ADHD. Primary Evidence-Base Briefing No 1. Focus Project London; Royal College of Psychiatrists' Research Unit 1999
    Google Scholar
  • 9 World Health Organization .International Classification of Diseases. New York; World Health Organization Publications 2002
    Google Scholar
  • 10 British Psychological Society .Attention Deficit Hyperactivity Disorder (ADHD): a Psychological Response to an Evolving Concept. Leicester, England; The British Psychological Society 1996
    Google Scholar
  • 11 American Speech-Language-Hearing Association .Technical Report on the Roles of Audiologists and Speech-Language Pathologists Working With Students With Attention Deficit Hyperactivity Disorder. Rockville, MD; ASHA 1996
    Google Scholar
  • 12 American Academy of Child and Adolescent Psychiatry . Practice parameters for the assessment and treatment of children, adolescents and adults with ADHD.  J Am Acad Child Adolesc Psychiatry. 1997;  36 85S-121S
    PubMedGoogle Scholar
  • 13 American Academy of Pediatrics . Clinical practice guideline-treatment of the child with attention deficit/hyperactivity disorder (AC0002).  Pediatrics. 2000;  108 1033-1044
    PubMedGoogle Scholar
  • 14 Brock S E. Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD) in Childhood: a Review of the Literature. (ERIC Document Reproduction Service No. ED 410512) Anaheim, CA; National Association of School Psychologists 1997
    Google Scholar
  • 15 National Institutes of Health . Consensus statement: diagnosis and treatment of attention deficit hyperactivity disorder.  J Am Acad Child Adolesc Psychiatry. 2000;  39 182-193
    PubMedGoogle Scholar
  • 16 Greydanus D E. Psychopharmacology for ADHD in adolescents: quo vadis?.  Psychiat Times. 2003;  44 48-55
    PubMedGoogle Scholar
  • 17 Ingram S, Hechman I, Morgenstern G. Outcome issues in ADHD: adolescent and adult long-term outcome.  Ment Retard Dev Disord Res Rev. 1999;  5 243-250
    PubMedGoogle Scholar
  • 18 Mannuzza S, Klein R G, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up.  Am J Psychiatry. 1998;  155 493-498
    Google Scholar
  • 19 Boyajian A E, DuPaul G J, Handler M W, Eckert T L, McGoey K E. The use of classroom-based behavior functional analyses with preschoolers at risk for attention deficit hyperactivity disorder.  School Psychol Rev. 2001;  30 278-293
    PubMedGoogle Scholar
  • 20 Connor D F. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment.  J Dev Behav Pediatr. 2002;  23(Suppl I) S1-S9
    PubMedGoogle Scholar
  • 21 Loughran S B. Agreement and stability of teacher rating scales for assessing ADHD in preschoolers.  Early Child Ed J. 2003;  30 247-253
    PubMedGoogle Scholar
  • 22 Armstrong M B, Nettleton S. Attention deficit/hyperactivity disorder and preschool children.  Semin Speech Lang. 2004;  25 225-232
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Pierce C D, Reid R. Attention deficit hyperactivity disorder: assessment and treament of children from culturally different groups.  Semin Speech Lang. 2004;  25 233-240
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder.  J Am Acad Child Adolesc Psychiatry. 1997;  36(Suppl 10) 85S-121S
    PubMedGoogle Scholar
  • 25 Jerrell J M. Are assessment and treatment influenced by ethnicity and gender?.  Psychiat Times. 2003;  44 71-74
    PubMedGoogle Scholar
  • 26 Ridley C R, Li L C, Hill C L. Multicultural assessment: reexamination, reconceptualization, and practical application.  Couns Psychol. 1998;  26 827-910
    PubMedGoogle Scholar
  • 27 Damico J S, Muller N, Ball M J. Owning up to complexity: a sociocultural orientation to attention deficit hyperactivity disorder.  Semin Speech Lang. 2004;  25 277-284
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Barkley R A. ADHD and the Nature of Self-Control. New York; Guilford Press 1997
    Google Scholar
  • 29 Barkley R A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD.  Psychol Bull. 1997;  121 65-94
    CrossrefPubMedGoogle Scholar
  • 30 Damico J S, Damico S K, Armstrong M B. Attention-deficit hyperactivity disorder and communicative disorders.  Child Adol Psych Clinics N Am. 1999;  8 37-60
    PubMedGoogle Scholar
  • 31 Westby C E, Cutler S K. Language and ADHD: understanding the bases and treatment of self-regulatory deficits.  Top Lang Disord. 1994;  14 58-76
    PubMedGoogle Scholar
  • 32 Westby C, Watson S. Perspectives on attention deficit hyperactivity disorder: executive functions, working memory, and language disabilities.  Semin Speech Lang. 2004;  25 241-254
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Dunaway C. Attention deficit hyperactivity disorder: an authentic story in the schools and its implications.  Semin Speech Lang. 2004;  25 271-276
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Nelson R, Hawley H. Inner control as an operational mechanism in attention deficit hyperactivity disorder.  Semin Speech Lang. 2004;  25 255-262
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Greenhill L L, Halperin J M, Abikoff H. Stimulant medications.  J Am Acad Child Adolesc Psychiatry. 1999;  35 503-512
    PubMedGoogle Scholar
  • 36 Hechtman L, Greenfield B. Long-term use of stimulants in children with attention deficit hyperactivity disorder. Safety, efficacy, and long-term outcome.  Pediatr Drugs. 2003;  5 787-794
    PubMedGoogle Scholar
  • 37 Kollins S H, Barkley R A, DuPaul G J. Use and management of medications for children diagnosed with attention deficit/hyperactivity disorder (ADHD).  Focus Except Child. 2001;  33 1-24
    PubMedGoogle Scholar
  • 38 Popper C W. Pharmacological alternatives to psychostimulants for the treatment of attention deficit/hyperactivity disorder.  Child Adol Psych Clinics of N Am. 2002;  9 605-646
    PubMedGoogle Scholar
  • 39 Zito J M, Safer D J, dos Reis S et al.. Trends in the prescribing of psychotropic medication to preschoolers.  JAMA. 2000;  283 1025-1030
    CrossrefPubMedGoogle Scholar
  • 40 Accardo P A, Blondis T A. What's all the fuss about Ritalin?.  J Pediatr. 2001;  138 6-9
    CrossrefPubMedGoogle Scholar
  • 41 DeBar L L, Lynch F, Powell J, Gale J. Use of psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization.  Arch Pediatr Adolesc Med. 2003;  157 150-157
    PubMedGoogle Scholar
  • 42 McGoey K E, Eckert T L, DuPaul G. Early intervention for preschool-age children with ADHD: a literature review.  J Emot Behav Disord. 2002;  10 14-28
    PubMedGoogle Scholar
  • 43 Rappley M D, Mullen P B, Alvarez F J et al.. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.  Arch Pediatr Adolesc Med. 1999;  153 1039-1045
    PubMedGoogle Scholar
  • 44 Barkley R A. Attention-Deficit Hyperactivity Disorder: a Handbook for Diagnosis and Treatment, 2nd ed. New York; Guilford Press 1998
    Google Scholar
  • 45 Greenhill L L, Pliszka S, Dulcan M K et al.. Practice parameter for the use of stimulant medications in treatment of children, adolescent, and adults.  J Am Acad Child Adolesc Psychiatry. 2002;  41(Suppl 2) 26S-49S
    PubMedGoogle Scholar
  • 46 Greydanus D E, Patel D R. Sports doping in the adolescent athlete: the hope, hype, and hyperbole.  Pediatr Clin North Am. 2002;  49 829-855
    CrossrefPubMedGoogle Scholar
  • 47 Greydanus D E, Sloane M A, Rappley M D. Psychopharmacology of ADHD in adolescents.  Adolesc Med. 2002;  13 599-624
    PubMedGoogle Scholar
  • 48 Schachter H M, Pham B, King J et al.. How efficacious and safe is short-acting methylphenidate for the treatment of attention deficit disorder in children and adolescents: a meta-analysis.  Can Med Assoc J. 2001;  165 1475-1488
    PubMedGoogle Scholar
  • 49 Solanto M V, Arnsten A FT, Castellanos F X. The neuroscience of stimulant drug action in ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX Stimulant Drugs and ADHD: Basic and Clinical Neuroscience Oxford; Oxford University Press 2001: 355-379
    Google Scholar
  • 50 Eli Lilly and Company .Package insert: Strattera. Indianapolis, IN; Eli Lilly 2002
    Google Scholar
  • 51 MTA Cooperative Group . 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder.  Arch Gen Psychiatry. 1999;  56 1073-1086
    Google Scholar
  • 52 Carey W B. What the multimodal treatment study of children with ADHD did and did not say about the use of methylphenidate for attention deficits.  Pediatrics. 2000;  105 863-864
    CrossrefPubMedGoogle Scholar
  • 53 Pelham W E. The NIMH multimodal treatment study for attention deficit hyperactivity disorder: just say yes to drugs alone?.  Can J Psychiatry. 1999;  44 981-990
    PubMedGoogle Scholar
  • 54 Tetnowski J A. Attention deficit hyperactivity disorder and concomitant communicative disorders.  Semin Speech Lang. 2004;  25 215-224
    Article in Thieme ConnectPubMedGoogle Scholar

Jack S DamicoPh.D. 

Department of Communicative Disorders, The University of Louisiana at Lafayette

P.O. Box 43170, Lafayette, LA 70504-3170

Email: jsdamico@louisiana.edu

      >